SEC Filing Summary: Form 6-K
Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV, a foreign private issuer headquartered in Mechelen, Belgium. The filing date is February 10, 2026. The report serves to incorporate by reference a press release issued on the same date (Exhibit 99.1) into the Company's various Registration Statements on Form S-8. The filing text does not explicitly detail the specific content of the press release or the business context of the announcement.
Key Financial Metrics
The filing text does not provide specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing is a procedural vehicle to distribute a press release rather than a financial statement.
Material Changes
No material changes to financial position or operations are described in the provided text. The document solely references the issuance of a press release without summarizing its contents or comparing them to prior periods.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. Investors must refer to the attached Exhibit 99.1 (the press release) for any such information, as the text of the press release is not included in the input provided.
Key Facts for Investor Verification
- Company Identity: Verify that the registrant is Galapagos NV, not Lakefront Biotherapeutics NV (which appears in the request metadata but not the filing text).
- Press Release Content: The core information of this filing is contained in Exhibit 99.1, which is not included in the provided text; investors must locate the original press release dated February 10, 2026.
- Registration Statements: The press release is incorporated into multiple Form S-8 registration statements (File Nos. 333-204567 through 333-292050).
- Financial Data: No financial metrics are available in this specific filing document.